Kosan Biosciences, Inc. (former stock symbol: KOSN), was a pharmaceutical company which dealt with cancer therapeutics medications. Their technology platform was based on manipulation of the genetic instructions of microbes for making natural product polyketides. Rearranging the modular units in natural polyketide synthases, combining modules from different enzymes, and incorporating novel synthetic chemical starter units enables them to produce a wide variety of novel polyketides that would be difficult to obtain via organic synthesis alone.
Founded in 1995, Kosan was headquartered in Hayward, California and employed approximately 90 people. Kosan was funded in part as a venture capital start-up with funds from Sofinnova Ventures of California. On June 26, 2008, Kosan Biosciences was acquired by Bristol-Myers Squibb.
Most of my consulting work with Kosan involved the design, development, and execution of large format scientific posters for trade shows.